Organon & Co (OGN)
16.00
+0.28
(+1.78%)
USD |
NYSE |
Jan 08, 16:00
15.84
-0.16
(-1.00%)
Pre-Market: 08:01
Organon SG&A Expense (Quarterly): 422.00M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Merck & Co Inc | 2.731B |
| Sage Therapeutics Inc | 53.22M |
| NovaBay Pharmaceuticals Inc | 2.65M |
| Palatin Technologies Inc | 2.021M |
| iBio Inc | 2.801M |